Smartwatch study aims to spot opioid use and withdrawal

NCT ID NCT07405398

Recruiting now Knowledge-focused Sponsor: OpiAID Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a smartwatch can detect when someone uses opioids or experiences withdrawal. Researchers will collect biometric data from 420 people with opioid use disorder who wear the watch for 14 days. The goal is to train a machine learning algorithm to recognize these events, which could eventually help monitor treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Samsung Galaxy Watch wearable device
What this could lead to: If successful, this could lead to a wearable device that helps detect opioid use and withdrawal, potentially improving treatment monitoring.
What could go wrong: This is an early-stage observational study focused on training an algorithm, not testing a treatment. The device may not be accurate enough for real-world use, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TREATMENT FOR OPIOID USE DISORDER

Contacts and locations

Locations

Coastal Horizon
RECRUITING

Wilmington, North Carolina, 28409, United States
Community Medical Services
RECRUITING

Austin, Texas, 78745, United States
Community Medical Services
RECRUITING

Austin, Texas, 78753, United States
Community Medical Services
RECRUITING

Cedar Park, Texas, 78613, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.